Home »
PBI-Gordon Companies commends this decision affirming the U.S. Environmental Protection Agency’s (EPA) congressionally mandated authority to establish consistent, science-based pesticide labeling.
Ribbon cutting ceremony highlights commitment to animal health and local community investment Pensacola, Fla. (September 17, 2025)– Pegasus Laboratories, a subsidiary of PBI-Gordon Companies and a leading manufacturer of veterinary pharmaceuticals, is hosting a...
Planned Transition to Leadership Structure Focused on Performance Management and People Development, A Hallmark of an Employee-Owned Company Shawnee, Kansas, – [Sept. 10, 2025] – PBI-Gordon Companies, Inc. today announced that its multi-year strategic growth...
PBI-Gordon Companies is excited to announce six students have been selected as the 2025 recipients of the William Everett and Mary Ellen Mealman Scholarship. Established in 2009, the William Everett and Mary Ellen Mealman Scholarship is a living testament to the...
PBI-Gordon's CEO reveals how a recent acquisition could revolutionize feline heart health and significantly boost the company's growth trajectory.
The strategic combination brings leading-edge product Felycin®-CA1 (Sirolimus Delayed-Release Tablets) and innovative pipeline together with PRN® Pharmacal leading expertise in commercializing new therapies for chronic pet health conditions Shawnee, Kansas, May 5,...
Shawnee, KS, December 2024 - PBI-Gordon Companies is proud to support Operation Breakthrough this holiday season by donating over 50 toys to brighten the holidays for children in need. Among the gifts donated were basketball hoops, skateboards, backpacks, piano...
Hampshire, IL, April 2024 – Jonathan Ochoa has joined animal health solution provider PetAg, Inc. As the Vice President of Marketing, Ochoa is responsible for developing and executing the marketing strategy and go-to-market plans to support PetAg financial goals,...
PBI-Gordon Companies commends this decision affirming the U.S. Environmental Protection Agency’s (EPA) congressionally mandated authority to establish consistent, science-based pesticide labeling.
Ribbon cutting ceremony highlights commitment to animal health and local community investment Pensacola, Fla. (September 17, 2025)– Pegasus Laboratories, a subsidiary of PBI-Gordon Companies and a leading manufacturer of veterinary pharmaceuticals, is hosting a...
Planned Transition to Leadership Structure Focused on Performance Management and People Development, A Hallmark of an Employee-Owned Company Shawnee, Kansas, – [Sept. 10, 2025] – PBI-Gordon Companies, Inc. today announced that its multi-year strategic growth...
PBI-Gordon Companies is excited to announce six students have been selected as the 2025 recipients of the William Everett and Mary Ellen Mealman Scholarship. Established in 2009, the William Everett and Mary Ellen Mealman Scholarship is a living testament to the...
PBI-Gordon's CEO reveals how a recent acquisition could revolutionize feline heart health and significantly boost the company's growth trajectory.
The strategic combination brings leading-edge product Felycin®-CA1 (Sirolimus Delayed-Release Tablets) and innovative pipeline together with PRN® Pharmacal leading expertise in commercializing new therapies for chronic pet health conditions Shawnee, Kansas, May 5,...